Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Molecular Biology

• Publication date

  1992-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-2836(92)90106-TPMID 1613791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

  1992cited by this paper
• Proteolytic cleavage of the Alzheimer's disease amyloid A4 precursor protein.

  1991cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• Morphology and antibody recognition of synthetic beta-amyloid peptides.

  1991cited by this paper
• Proteolytic Cleavage of the Alzheimer's Disease Amyloid A4 Precursor Protein

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

  1991cited by this paper
• pH-dependent structural transitions of Alzheimer amyloid peptides.

  1991cited by this paper
• Morphology and antibody recognition of synthetic β‐amyloid peptides

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic beta-protein fragments.

  1990cited by this paper
• Alzheimer's β‐Amyloid Protein Is Covalently Modified when Dissolved in Formic Acid

  1990cited by this paper
• The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway.

  1990cited by this paper
• Intermediates in the folding reactions of small proteins.

  1990cited by this paper
• Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA.

  1990cited by this paper
• Enzyme specificity of proteinase inhibitor region in amyloid precursor protein of Alzheimer's disease: different properties compared with protease nexin I.

  1990cited by this paper
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing.

  1990cited by this paper
• Enzyme Activities in Relation to pH and Lactate in Postmortem Brain in Alzheimer‐Type and Other Dementias

  1990cited by this paper
• Cleavage of amyloid beta peptide during constitutive processing of its precursor.

  1990cited by this paper
• Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.

  1990cited by this paper
• Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease.

  1990cited by this paper
• The amyloid precursor protein of Alzheimer's disease is released by human platelets.

  1990cited by this paper
• Synthesis and secretion of Alzheimer amyloid βA4 precursor protein by stimulated human peripheral blood leucocytes

  1990cited by this paper
• Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease.

  1990cited by this paper
• Potential roles of protease inhibitors in Alzheimer's disease.

  1989cited by this paper
• Is amyloid deposition in Alzheimer's disease preceded by an environment-induced double conformational transition?

  1989cited by this paper
• Molecular biology of Alzheimer's disease.

  1989cited by this paper
• Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease

  1989cited by this paper
• Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein

  1989cited by this paper
• Isoelectric points of proteins: theoretical determination.

  1989cited by this paper
• Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.

  1989cited by this paper
• Biochemistry of altered brain proteins in Alzheimer's disease.

  1989cited by this paper
• Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.

  1989cited by this paper
• Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein.

  1989cited by this paper
• Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

  1988cited by this paper
• Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

  1988cited by this paper
• The site of the earliest lesions of Alzheimer's disease.

  1988cited by this paper
• Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease.

  1988cited by this paper
• Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• Different processing of Alzheimer's beta-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type.

  1988cited by this paper
• Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques.

  1988cited by this paper
• Human amyloidosis, Alzheimer disease and related disorders.

  1988cited by this paper
• Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues.

  1988cited by this paper
• Alzheimer's disease: Its proteins and genes

  1988cited by this paper
• Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix.

  1988cited by this paper
• The site of the earliest lesions of Alzheimer's disease.

  1988cited by this paper
• Diffuse type of senile plaques in the brains of Alzheimer-type dementia

  1988cited by this paper
• Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern.

  1987cited by this paper
• Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.

  1987cited by this paper
• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

  1987cited by this paper
• Effect of 5-minute ischemia on regional pH and energy state of the gerbil brain: relation to selective vulnerability of the hippocampus.

  1987cited by this paper
• Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease.

  1987cited by this paper
• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

  1987cited by this paper
• X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.

  1986cited by this paper
• Aluminosilicates and senile plaque formation in Alzheimer's disease.

  1986cited by this paper
• Calculation of protein conformation from circular dichroism.

  1986cited by this paper
• Solution structure of human growth hormone releasing factor. Combined use of circular dichroism and nuclear magnetic resonance spectroscopy.

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Acid-base homeostasis in the brain: physiology, chemistry, and neurochemical pathology.

  1985cited by this paper
• Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

  1984cited by this paper
• Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

  1984cited by this paper
• 1Acid-base balance in metabolic acidoses

  1983cited by this paper
• Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonance.

  1983cited by this paper
• Acid-base balance in metabolic acidoses.

  1983cited by this paper
• A salt bridge stabilizes the helix formed by isolated C-peptide of RNase A.

  1982cited by this paper
• Ageing of the brain and dementia

  1980cited by this paper
• Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroism.

  1980cited by this paper
• Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

  1980cited by this paper
• Circular dichroic analysis of protein conformation: inclusion of the beta-turns.

  1978cited by this paper
• Changes in pH within the phagocytic vacuoles of human neutrophils and monocytes.

  1978cited by this paper
• Changes in pH within the phagocytic vacuoles of human neutrophils and monocytes.

  1978cited by this paper
• On the conformation of proteins: hydrophobic ordering of strands in beta-pleated sheets.

  1977cited by this paper
• Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine.

  1973cited by this paper
• The circular dichroism of beta-poly-L-lysine.

  1969cited by this paper
• Computed circular dichroism spectra for the evaluation of protein conformation.

  1969cited by this paper
• Ultraviolet rotatory properties of polypeptides in solution. II. Poly-L-serine.

  1968cited by this paper
• Smoothing and differentiation of data by simplified least square procedure.

  1964cited by this paper
• Journal of Cerebral Blood Flow and Metabolism Hydrogen Ions Kill Brain at Concentrations Reached in Ischemia

  year unknowncited by this paper

• Insights into the Destabilizing Effect of Fluorinated Ethanol on Biomimetic Membranes.

  2026cites this paper
• Aggregation, stabilization, and binding between bovine serum albumin and gold nanoparticles of varying sizes

  2025cites this paper
• Decoding the Relationship between Alzheimer's Disease and Type-2 Diabetes via the Protein Aggregation Prism.

  2025cites this paper
• Synthesis and mechanistic investigation of short peptides as Aβ aggregation inhibitors.

  2025cites this paper
• Mass-Spectrometry-Based GEE Footprinting Characterizes Kinetic Mechanisms and Sites of Conformational Change in Amyloid β 1-42 Aggregation.

  2025cites this paper
• Non-standard proteins in the lens of AlphaFold 3 - a case study of amyloids

  2025cites this paper
• Oligomerization Mechanism of Amyloid-β Peptides at Hydrophobic Interfaces Revealed by Molecular Dynamics Simulations.

  2025cites this paper
• Comparative Molecular Insights into the Interaction of Dobutamine, Quercetin, and Fisetin with Amyloid Beta Monomer and Protofibril

  2025cites this paper
• Molecular Dynamics Simulations of Monomeric and Tetrameric Amyloid β1‐42 Peptides with d‐Aspartic Acid Residues

  2025cites this paper
• Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications

  2025cites this paper
• Molecular dynamics simulations of amyloid-β(29–42) aggregation in bulk water and at the air–water interface

  2025cites this paper
• Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools

  2024cites this paper
• Targeting the hydrophobic region of pyroglutamate‐modified amyloid‐β by tyrocidine A prevents its nucleation–aggregation process and its “catalytic effect” on the Aβs aggregation

  2024cites this paper
• Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease.

  2024cites this paper
• Protein Corona Formation and Aggregation of Amyloid β 1-40-Coated Gold Nanocolloids.

  2024cites this paper
• Probing the Conformational Ensemble of the Amyloid Beta 16-22 Fragment with Parallel-Bias Metadynamics.

  2024cites this paper
• Bioconversion of waste glycerol into viscosinamide by Pseudomonas fluorescens DR54 and its activity evaluation

  2024cites this paper
• A VEGF Fragment Encompassing Residues 10-30 Inhibits Aβ1-42 Amyloid Aggregation and Exhibits Neuroprotective Properties Matching the Full-Length Protein.

  2024cites this paper
• Reversible and size-controlled assembly of reflectin proteins using a charged azobenzene photoswitch

  2024cites this paper
• Profiling of the Proteins Interacting with Amyloid Beta Peptides in Clinical Samples by PACTS-TPP.

  2024cites this paper
• Advancing Synthetic Hydrogels through Nature‐Inspired Materials Chemistry

  2024cites this paper
• Upgrading of the general AMBER force field 2 for fluorinated alcohol biosolvents: A validation for water solutions and melittin solvation

  2023cites this paper
• Connection of brain glymphatic system with circadian rhythm

  2023cites this paper
• Hierarchical assembly of tryptophan zipper peptides into stress-relaxing bioactive hydrogels

  2023cites this paper
• Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection.

  2023cites this paper
• Role of water in physics of blood and cerebrospinal fluid

  2023cites this paper
• Identification of new pentapeptides as potential inhibitors of amyloid-β42 aggregation using virtual screening and molecular dynamics simulations.

  2023cites this paper
• Influence of elevated temperature and high pressure treatments on structural changes of soy protein concentrate

  2023cites this paper
• Aggregation of Disordered Proteins Associated with Neurodegeneration

  2023cites this paper
• Structural factors governing binding of curvature-sensing peptides to bacterial extracellular vesicles covered with hydrophilic polysaccharide chains.

  2023cites this paper
• Vitamin E modified polyamidoamine dendrimer for piperine delivery to alleviate Aβ1–42 induced neurotoxicity in Balb/c mice model

  2023cites this paper
• Label free visualization of amyloid plaques in Alzheimer's disease with polarization-sensitive photoacoustic Mueller matrix tomography

  2022cites this paper
• The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease

  2022cites this paper
• Putative Structures of Membrane-Embedded Amyloid β Oligomers.

  2022cites this paper
• Molecular Dynamics Simulation Studies on the Aggregation of Amyloid-β Peptides and Their Disaggregation by Ultrasonic Wave and Infrared Laser Irradiation

  2022cites this paper
• Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease

  2022cites this paper
• Tin oxide nanoparticles trigger the formation of amyloid β oligomers/protofibrils and underlying neurotoxicity as a marker of Alzheimer's diseases.

  2022cites this paper
• All-Atom Molecular Dynamics Simulation Methods for the Aggregation of Protein and Peptides: Replica Exchange/Permutation and Nonequilibrium Simulations.

  2022cites this paper
• Formulation and optimization of silymarin-encapsulated binary micelles for enhanced amyloid disaggregation activity

  2021cites this paper
• Helix-coil transition and conformational deformity in Aβ 42-monomer: a case study using the Zn2+ cation

  2021cites this paper
• AlphaFold and the amyloid world.

  2021cites this paper
• Surface Plasmon Resonance Assay for Identification of Small Molecules Capable of Inhibiting Aβ Aggregation.

  2021cites this paper
• Regulatory principles on food nano-particles legislated by international organizations

  2021cites this paper
• Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments.

  2021cites this paper
• The interplay between lipid and Aβ amyloid homeostasis in Alzheimer's Disease: risk factors and therapeutic opportunities.

  2021cites this paper
• Strong acids induce amyloid fibril formation of β2-microglobulin via an anion-binding mechanism

  2021cites this paper
• Amyloid-Mediated Mechanisms of Membrane Disruption

  2021cites this paper
• Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer’s disease cognition

  2021cites this paper
• Kinetic and thermodynamic stability comparison for the fibrillar form of small amyloid-β(1-42) oligomers using scaled molecular dynamics.

  2021cites this paper
• Reproducibility Problems of Amyloid-β Self-Assembly and How to Deal With Them

  2021cites this paper
• Design of the N-Terminus Substituted Curvature-Sensing Peptides That Exhibit Highly Sensitive Detection Ability of Bacterial Extracellular Vesicles.

  2021cites this paper
• Arabidopsis thaliana Plant Natriuretic Peptide Active Domain Forms Amyloid-like Fibrils in a pH-Dependent Manner

  2021cites this paper
• The construction of resveratrol-loaded protein-polysaccharide-tea saponin complex nanoparticles for controlling physicochemical stability and in vitro digestion.

  2020cites this paper
• Novel isatin thiosemicarbazone derivatives as potent inhibitors of β-amyloid peptide (Αβ) aggregation and toxicity.

  2020cites this paper
• How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models

  2020cites this paper
• Resveratrol-mediated cleavage of amyloid β1-42 peptide: potential relevance to Alzheimer's disease.

  2020cites this paper
• Liposomes Decorated with 2-(4'-Aminophenyl)benzothiazole Effectively Inhibit Aβ1-42 Fibril Formation and Exhibit in Vitro Brain-Targeting Potential.

  2020cites this paper
• Influence of calcium ions on the stability, microstructure and in vitro digestion fate of zein-propylene glycol alginate-tea saponin ternary complex particles for the delivery of resveratrol

  2020cites this paper
• Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42

  2020cites this paper
• Vescalagin and castalagin reduce the toxicity of amyloid-beta42 oligomers through the remodelling of its secondary structure.

  2020cites this paper
• Analyzing microglial-associated Aβ in Alzheimer’s disease transgenic mice with a novel mid-domain Aβ-antibody

  2020cites this paper
• Piezoelectric materials for ultrasound-driven dissociation of Alzheimer's β-amyloid aggregate structure.

  2020cites this paper
• Fabrication, characterization and in vitro digestion of food grade complex nanoparticles for co-delivery of resveratrol and coenzyme Q10

  2020cites this paper
• Nanomaterials to avoid and destroy protein aggregates

  2020cites this paper
• Edaravone inhibits the conformational transition of amyloid-β42: insights from molecular dynamics simulations

  2020cites this paper
• Replica-permutation molecular dynamics simulations of an amyloid-β(16–22) peptide and polyphenols

  2020cites this paper
• Effects of in vivo conditions on amyloid aggregation.

  2019cites this paper
• Effect of temperature and pH on the secondary structure and denaturation process of jumbo squid hepatopancreas cathepsin D.

  2019cites this paper
• Preferential Binding of Cytochrome c to Anionic Ligand-Coated Gold Nanoparticles: A Complementary Computational and Experimental Approach.

  2019cites this paper
• Amyloid-β(29-42) Dimeric Conformations in Membranes Rich in Omega-3 and Omega-6 Polyunsaturated Fatty Acids.

  2019cites this paper
• X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.

  2019cites this paper
• Characterization of Changes due to pH Variations in Beta Peptide (25–35) Leading to Alzheimer’s Disease

  2019cites this paper
• Energy Landscapes for Proteins: From Single Funnels to Multifunctional Systems

  2019cites this paper
• Conformational change of L-phenylalanine in fluorinated alcohol-water mixed solvents studied by IR, NMR, and MD simulations

  2019cites this paper
• Examination of Adsorption Orientation of Amyloidogenic Peptides Over Nano-Gold Colloidal Particle Surfaces

  2019cites this paper
• Challenges in understanding the structure/activity relationship of Aβ oligomers

  2019cites this paper
• Comparative analysis of the metal-dependent structural and functional properties of mouse and human SMP30

  2019cites this paper
• The in vitro synergistic denaturation effect of heat and surfactant on photosystem I isolated from Arthrospira Platensis

  2019cites this paper
• A comparative study on the effect of structural variations of co-solvent on the Tetronic® micelles with widely different hydrophobicity

  2019cites this paper
• Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease

  2018cites this paper
• Structural Interconversion in Alzheimer's Amyloid-β(16-35) Peptide in an Aqueous Solution.

  2018cites this paper
• Structural discordance in HIV-1 Vpu from brain isolate alarms amyloid fibril forming behavior- a computational perspective.

  2018cites this paper
• The Un(f)told Story of General Anesthesia

  2018cites this paper
• Influence of electric field on the amyloid-β(29-42) peptides embedded in a membrane bilayer.

  2018cites this paper
• Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

  2018cites this paper
• Direct synthesis of ultralong platinum nanowires with prominent electrocatalytic performance using lanreotide biotemplate

  2018cites this paper
• Effects of Surface Coating on Nanoparticle-Protein Adsorption Selectivity

  2018cites this paper
• Differential interaction of α-synuclein N-terminal segment with mitochondrial model membranes.

  2018cites this paper
• Preparation of defect free TFC FO membranes using robust and highly porous ceramic substrate

  2018cites this paper
• Assembly Pathway Selection of Designer Self-Assembling Peptide and Fabrication of Hierarchical Scaffolds for Neural Regeneration.

  2018cites this paper
• Polymorphism of Alzheimer’s Aβ Amyloid Fibrils and Oligomers

  2018cites this paper
• Engineering escherichia coli for nanoparticle synthesis and targeting of colon cancer

  2018cites this paper
• Recent Advances by In Silico and In Vitro Studies of Amyloid-β 1-42 Fibril Depicted a S-Shape Conformation

  2018cites this paper
• Fluorinated Alcohols' Effects on Lipid Bilayer Properties.

  2018cites this paper
• Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer’s disease amyloid-β protein aggregation

  2017cites this paper
• Transmission des lésions amyloïdes de la maladie d’Alzheimer : apports des modèles animaux

  2017cites this paper
• The molecular behavior of a single β‐amyloid inside a dipalmitoylphosphatidylcholine bilayer at three different temperatures: An atomistic simulation study: Aβ interaction with DPPC: Atomistic simulation

  2017cites this paper
• Purification of recombinant Aβ(1‐42) and pGlu‐Aβ(3‐42) using preparative SDS‐PAGE

  2017cites this paper
• Molecular Self‐Assembly for Nanobiomaterial Fabrication

  2017cites this paper
• Inhibition Mechanisms of a Pyridazine-Based Amyloid Inhibitor: As a β-Sheet Destabilizer and a Helix Bridge Maker.

  2017cites this paper